COMP <GO>
NXTC vs PMN // ALTMAN Z-SCORE & DEBT/EQUITY
NextCure Inc. (NASDAQ) VS. ProMIS Neurosciences Inc. (ON) (NASDAQ) • 15-METRIC TALLY: NXTC 2
— PMN 1
■ METRIC PARITY
LAST: $5.70 (-9.75%) • MKT CAP: $28.9M
balance-sheet
—
LAST: $3.00 (-9.37%) • MKT CAP: $29.7M
balance-sheet
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (NXTC VS. PMN)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | NXTC | PMN | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | -35.00% | 0.00 | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | — | — | TIE | /fcf-yield <GO> |
| Operating Margin | — | — | — | TIE | /operating-margins <GO> |
| Net Profit Margin | — | — | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | — | — | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity ACTIVE | — | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 2/9 | 1/9 | +1.00 | NXTC | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 53.8 | 28.2 | +25.60 | NXTC | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $28.9M | $29.7M | -$799.9K | PMN | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | NXTC REV | PMN REV | NXTC GROSS % | PMN GROSS % | NXTC FCF | PMN FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $161.3M | $112.5M | — | — | -$49.6M | -$28.1M |
| FY 2024 | $167.3M | $47.1M | — | — | -$41.3M | -$27.2M |
| FY 2023 | $189.4M | $39.9M | — | — | -$53.0M | -$10.8M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
NXTC // BETA —
PMN // BETA —